Table of Contents Author Guidelines Submit a Manuscript
International Journal of Otolaryngology
Volume 2011, Article ID 638058, 6 pages
http://dx.doi.org/10.1155/2011/638058
Review Article

Early Detection of Nasopharyngeal Carcinoma

Department of Otolaryngology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8575, Japan

Received 1 December 2010; Revised 8 March 2011; Accepted 19 April 2011

Academic Editor: Leonard P. Rybak

Copyright © 2011 Keiji Tabuchi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. S. T. Sham, W. I. Wei, Z. Yong-Sheng et al., “Detection of subclinical nasopharyngeal carcinoma by fibreoptic endoscopy and multiple biopsy,” The Lancet, vol. 335, no. 8686, pp. 371–374, 1990. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Agulnik and J. B. Epstein, “Nasopharyngeal carcinoma: current management, future directions and dental implications,” Oral Oncology, vol. 44, no. 7, pp. 617–627, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. A. Fandi, M. Altun, N. Azli, J. P. Armand, and E. Cvitkovic, “Nasopharyngeal cancer: epidemiology, staging, and treatment,” Seminars in Oncology, vol. 21, no. 3, pp. 382–397, 1994. View at Google Scholar · View at Scopus
  4. Homepage of Surveillance Epidemiology and End Results (SEER) Program. U.S. National Cancer Institute.
  5. D. P. Huang, “Epidemiology of nasopharyngeal carcinoma,” Ear, Nose and Throat Journal, vol. 69, no. 4, pp. 222–224, 1990. View at Google Scholar · View at Scopus
  6. D. Jeannel, M. Ghnassia, A. Hubert et al., “Increased risk of nasopharyngeal carcinoma among males of French origin born in Maghreb (North Africa),” International Journal of Cancer, vol. 54, no. 4, pp. 536–539, 1993. View at Google Scholar · View at Scopus
  7. P. Buell, “The effect of migration on the risk of nasopharyngeal cancer among Chinese,” Cancer Research, vol. 34, no. 5, pp. 1189–1191, 1974. View at Google Scholar · View at Scopus
  8. R. I. Dickson, “Nasopharyngeal carcinoma: an evaluation of 209 patients,” Laryngoscope, vol. 91, no. 3, pp. 333–354, 1981. View at Google Scholar · View at Scopus
  9. W. I. Wei and J. S. T. Sham, “Nasopharyngeal carcinoma,” The Lancet, vol. 365, no. 9476, pp. 2041–2054, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. X. Zhou, J. Cui, A. A. Kajdacsy-Balla, H. Ye, J. Wang, and P. N. Rao, “The progress on genetic analysis of nasopharyngeal carcinoma,” Comparative and Functional Genomics, vol. 2007, Article ID 57513, 2007. View at Publisher · View at Google Scholar · View at PubMed
  11. E. T. Chang and H. O. Adami, “The enigmatic epidemiology of nasopharyngeal carcinoma,” Cancer Epidemiology Biomarkers and Prevention, vol. 15, no. 10, pp. 1765–1777, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. J. H. C. Ho, “An epidemiologic and clinical study of nasopharyngeal carcinoma,” International Journal of Radiation Oncology Biology Physics, vol. 4, no. 3-4, pp. 183–198, 1978. View at Google Scholar · View at Scopus
  13. A. B. Rickinson and E. Kieff, “Epstein-Barr virus,” in Field’s virology, D. M. Knipe and P. M. Howley, Eds., pp. 2575–2627, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 4th edition, 2001. View at Google Scholar
  14. H. O. Kangro, H. K. Osman, Y. L. Lau, R. B. Heath, C. Y. Yeung, and M. H. Ng, “Seroprevalence of antibodies to human herpesviruses in England and Hong Kong,” Journal of Medical Virology, vol. 43, no. 1, pp. 91–96, 1994. View at Google Scholar · View at Scopus
  15. B. E. Henderson and E. Louie, “Discussion of risk factors for nasopharyngeal carcinoma,” IARC, vol. 20, pp. 251–261, 1978. View at Google Scholar · View at Scopus
  16. M. C. Yu, J. H. C. Ho, R. K. Ross, and B. E. Henderson, “Nasopharyngeal carcinoma in Chinese—salted fish or inhaled smoke?” Preventive Medicine, vol. 10, no. 1, pp. 15–24, 1981. View at Google Scholar · View at Scopus
  17. M. C. Yu, J. H. C. Ho, S. H. Lai, and B. E. Henderson, “Cantonese-style salted fish as a cause of nasopharyngeal carcinoma: report of a case-control study in Hong Kong,” Cancer Research, vol. 46, no. 2, pp. 956–961, 1986. View at Google Scholar · View at Scopus
  18. M. C. Yu, P. W. Nichols, X. N. Zou, J. Estes, and B. E. Henderson, “Induction of malignant nasal cavity tumours in Wistar rats fed Chinese salted fish,” British Journal of Cancer, vol. 60, no. 2, pp. 198–201, 1989. View at Google Scholar · View at Scopus
  19. M. C. Yu, T. B. Huang, and B. E. Henderson, “Diet and nasopharyngeal carcinoma: a case-control study in Guangzhou, China,” International Journal of Cancer, vol. 43, no. 6, pp. 1077–1082, 1989. View at Google Scholar · View at Scopus
  20. R. W. Armstrong, P. B. Imrey, M. S. Lye, M. Jocelyn Armstrong, M. C. Yu, and S. Sani, “Nasopharyngeal carcinoma in malaysian chinese: salted fish and other dietary exposures,” International Journal of Cancer, vol. 77, no. 2, pp. 228–235, 1998. View at Publisher · View at Google Scholar · View at Scopus
  21. J. M. Yuan, X. L. Wang, Y. B. Xiang, Y. U. T. Gao, R. K. Ross, and M. C. Yu, “Preserved foods in relation to risk of nasopharyngeal carcinoma in Shanghai, China,” International Journal of Cancer, vol. 85, no. 3, pp. 358–363, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Zou, Q. Sun, S. Akiba et al., “A case-control study of nasopharyngeal carcinoma in the high background radiation areas of Yangjiang, China,” Journal of Radiation Research, vol. 41, pp. 53–62, 2000. View at Google Scholar · View at Scopus
  23. S. Poirier, A. Hubert, G. de-Thé, H. Ohshima, M. C. Bourgade, and H. Bartsch, “Occurrence of volatile nitrosamines in food samples collected in three high-risk areas for nasopharyngeal carcinoma,” IARC, no. 84, pp. 415–419, 1987. View at Google Scholar · View at Scopus
  24. D. P. Huang, J. H. C. Ho, D. Saw, and T. B. Tech, “Carcinoma of the nasal and paranasal regions in rats fed Cantonese salted marine fish,” IARC, vol. 20, pp. 315–331, 1978. View at Google Scholar · View at Scopus
  25. X. Zheng, Y. Luo, B. Christensson, and B. Drettner, “Induction of nasal and nasopharyngeal tumours in Sprague-Dawley rats fed with Chinese salted fish,” Acta Oto-Laryngologica, vol. 114, no. 1, pp. 98–104, 1994. View at Google Scholar · View at Scopus
  26. S. Preston-Martin, “N-nitroso compounds as a cause of human cancer,” IARC, no. 84, pp. 477–484, 1987. View at Google Scholar · View at Scopus
  27. X. N. Zou, S. H. Lu, and B. Liu, “Volatile N-nitrosamines and their precursors in Chinese salted fish—a possible etological factor for NPC in China,” International Journal of Cancer, vol. 59, no. 2, pp. 155–158, 1994. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. M. Shao, S. Poirier, H. Ohshima et al., “Epstein-Barr virus activation in Raji cells by extracts of preserved food from high risk areas for nasopharyngeal carcinoma,” Carcinogenesis, vol. 9, no. 8, pp. 1455–1457, 1988. View at Google Scholar · View at Scopus
  29. S. Poirier, G. Bouvier, C. Malaveille et al., “Volatile nitrosamine levels and genotoxicity of food samples from high-risk areas for nasopharyngeal carcinoma before and after nitrosation,” International Journal of Cancer, vol. 44, no. 6, pp. 1088–1094, 1989. View at Publisher · View at Google Scholar
  30. C. S. Chen, B. C. Pignatelli Malaveille, G. Bouvier et al., “Levels of direct-acting mutagens, total N-nitroso compounds in nitrosated fermented fish products, consumed in a high-risk area for gastric cancer in southern China,” Mutation Research, vol. 265, no. 2, pp. 211–221, 1992. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Hildesheim, R. J. Apple, C. J. Chen et al., “Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan,” Journal of the National Cancer Institute, vol. 94, no. 23, pp. 1780–1789, 2002. View at Google Scholar · View at Scopus
  32. J. X. Bei, Y. I. Li, W. H. Jia et al., “A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci,” Nature Genetics, vol. 42, no. 7, pp. 599–603, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. K. A. P. Tse, W. H. Su, K. P. Chang et al., “Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3,” American Journal of Human Genetics, vol. 85, no. 2, pp. 194–203, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. W. L. Zhang, Y. H. Zhou, L. Xiao et al., “Biomarkers of nasopharyngeal carcinoma,” Progress in Biochemistry and Biophysics, vol. 35, no. 1, pp. 7–13, 2008. View at Google Scholar · View at Scopus
  35. K Shanmugaratnam and L. H. Sobin, “Histological typing of tumors of the upper respiratory tract and ear,” in International Histological Classification of Tumors. No 19, K Shanmugaratnam and L. H. Sobin, Eds., pp. 32–33, WHO, Geneva, Switzerland, 1991. View at Google Scholar
  36. S. P. Reddy, W. F. Raslan, S. Gooneratne, S. Kathuria, and J. E. Marks, “Prognostic significance of keratinization in nasopharyngeal carcinoma,” American Journal of Otolaryngology, vol. 16, no. 2, pp. 103–108, 1995. View at Google Scholar · View at Scopus
  37. J. E. Marks, J. L. Phillips, and H. R. Menck, “The national cancer data base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma,” Cancer, vol. 83, no. 3, pp. 582–588, 1998. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Jeyakumar, T. M. Brickman, A. Jeyakumar, and T. Doerr, “Review of nasopharyngeal carcinoma,” Ear, Nose and Throat Journal, vol. 85, no. 3, pp. 168–184, 2006. View at Google Scholar · View at Scopus
  39. A. W. M. Lee, J. S. T. Sham, Y. F. Poon, and J. H. C. Ho, “Treatment of Stage I nasopharyngeal carcinoma: analysis of the patterns of relapse and the results of withholding elective neck irradiation,” International Journal of Radiation Oncology Biology Physics, vol. 17, no. 6, pp. 1183–1190, 1989. View at Google Scholar · View at Scopus
  40. W. I. Wei and D. L. W. Kwong, “Current management strategy of nasopharyngeal carcinoma,” Clinical and Experimental Otorhinolaryngology, vol. 3, no. 1, pp. 1–12, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. D. L. W. Kwong, J. S. T. Sham, D. T. T. Chua, D. T. K. Choy, G. K. H. Au, and P. M. Wu, “The effect of interruptions and prolonged treatment time in radiotherapy for nasopharyngeal carcinoma,” International Journal of Radiation Oncology Biology Physics, vol. 39, no. 3, pp. 703–710, 1997. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Al-Sarraf, M. LeBlanc, P. G. S. Giri et al., “Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099,” Journal of Clinical Oncology, vol. 16, no. 4, pp. 1310–1317, 1998. View at Google Scholar · View at Scopus
  43. B. Baujat, H. Audry, J. Bourhis et al., “Chemotherapy as an adjunct to radiotherapy in locally advanced nasopharyngeal carcinoma,” Cochrane Database of Systematic Reviews, no. 4, Article ID CD004329, 2006. View at Publisher · View at Google Scholar · View at PubMed
  44. J. P. Pignon, J. Bourhis, C. Domenge, and L. Designé, “Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data,” The Lancet, vol. 355, no. 9208, pp. 949–955, 2000. View at Google Scholar · View at Scopus
  45. A. T. C. Chan, P. M. L. Teo, R. K. Ngan et al., “Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial,” Journal of Clinical Oncology, vol. 20, no. 8, pp. 2038–2044, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. J. C. Lin, J. S. Jan, C. Y. Hsu, W. M. Liang, R. S. Jiang, and W. Y. Wang, “Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival,” Journal of Clinical Oncology, vol. 21, no. 4, pp. 631–637, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. Z. Yi, L. Yuxi, and L. Chunren, “Application of an immunoenzymatic method and an immunoautoradiographic method for a mass survey of nasopharyngeal carcinoma,” Intervirology, vol. 13, no. 3, pp. 162–168, 1980. View at Google Scholar
  48. Y. Zeng, L. G. Zhang, and H. Y. Li, “Serological mass survey for early detection of nasopharyngeal carcinoma in Wuzhou City, China,” International Journal of Cancer, vol. 29, no. 2, pp. 139–141, 1982. View at Google Scholar · View at Scopus
  49. E. C. B. Nadala, T. M. C. Tan, H. M. Wong, and R. C. Y. Ting, “ELISA for the detection of serum. And saliva IgA against the BMRFI gene product of Epstein-Barr virus,” Journal of Medical Virology, vol. 50, no. 1, pp. 93–96, 1996. View at Publisher · View at Google Scholar · View at Scopus
  50. F. De Vathaire, H. Sancho-Garnier, H. De-The et al., “Prognostic value of EBV markers in the clinical management of nasopharyngeal carcinoma (NPC): a multicenter follow-up study,” International Journal of Cancer, vol. 42, no. 2, pp. 176–181, 1988. View at Google Scholar · View at Scopus
  51. K. P. Chang, C. L. Hsu, Y. U. L. Chang et al., “Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma,” Oral Oncology, vol. 44, no. 8, pp. 784–792, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. M. F. Ji, D. K. Wang, Y. L. Yu et al., “Sustained elevation of Epstein-Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinoma,” British Journal of Cancer, vol. 96, no. 4, pp. 623–630, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  53. S. P. Hao, N. M. Tsang, and K. P. Chang, “Screening nasopharyngeal carcinoma by detection of the latent membrane protein 1 (LMP-1) gene with nasopharyngeal swabs,” Cancer, vol. 97, no. 8, pp. 1909–1913, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. N. M. Tsang, C. C. Chuang, C. K. Tseng et al., “Presence of the latent membrane protein 1 gene in nasopharyngeal swabs from patients with mucosal recurrent nasopharyngeal carcinoma,” Cancer, vol. 98, no. 11, pp. 2385–2392, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. K.-P. Chang, C.-C. Wu, H.-C. Chen et al., “Identification of candidate nasopharyngeal carcinoma serum biomarkers by cancer cell secretome and tissue transcriptome analysis: potential usage of cystatin A for predicting nodal stage and poor prognosis,” Proteomics, vol. 10, no. 14, pp. 2644–2660, 2010. View at Publisher · View at Google Scholar · View at PubMed
  56. Y. E. S. Wei, Y. H. Zheng, W. B. Liang et al., “Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis,” Cancer, vol. 112, no. 3, pp. 544–551, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  57. C. E. Tang, T. Tan, C. Li et al., “Identification of Galectin-1 as a novel biomarker in nasopharyngeal carcinoma by proteomic analysis,” Oncology Reports, vol. 24, no. 2, pp. 495–500, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. C. C. Wu, K. Y. Chien, N. M. Tsang et al., “Cancer cell-secreted proteomes as a basis for searching potential tumor markers: nasopharyngeal carcinoma as a model,” Proteomics, vol. 5, no. 12, pp. 3173–3182, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. F. M. Shebl, K. Bhatia, and E. A. Engels, “Salivary gland and nasopharyngeal cancers in individuals with acquired immunodeficiency syndrome in United States,” International Journal of Cancer, vol. 126, no. 10, pp. 2503–2508, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  60. A. C. Vlantis, W. F. Bower, J. K. S. Woo, M. C. F. Tong, and C. A. van Hasselt, “Endoscopic assessment of the nasopharynx: an objective score of abnormality to predict the likelihood of malignancy,” Annals of Otology, Rhinology and Laryngology, vol. 119, no. 2, pp. 77–81, 2010. View at Google Scholar · View at Scopus
  61. S. H. Ng, J. T. C. Chang, S. C. Chan et al., “Nodal metastases of nasopharyngeal carcinoma: patterns of disease on MRI and FDG PET,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 31, no. 8, pp. 1073–1080, 2004. View at Google Scholar · View at Scopus
  62. A. D. King, A. T. Ahuja, S. F. Leung et al., “Neck node metastases from nasopharyngeal carcinoma: MR imaging of patterns of disease,” Head and Neck, vol. 22, no. 3, pp. 275–281, 2000. View at Publisher · View at Google Scholar · View at Scopus
  63. W. T. Ng, A. W. M. Lee, W. K. Kan et al., “N-staging by magnetic resonance imaging for patients with nasopharyngeal carcinoma: pattern of nodal involvement by radiological levels,” Radiotherapy and Oncology, vol. 82, no. 1, pp. 70–75, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  64. C. M. Glastonbury, “Nasopharyngeal carcinoma: the role of magnetic resonance imaging in diagnosis, staging, treatment, and follow-up,” Topics in Magnetic Resonance Imaging, vol. 18, no. 4, pp. 225–235, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  65. A. D. King, A. C. Vlantis, K. S. S. Bhatia et al., “Primary nasopharyngeal carcinoma: diagnostic accuracy of MR imaging versus that of endoscopy and endoscopic biopsy,” Radiology, vol. 258, no. 2, pp. 531–537, 2011. View at Publisher · View at Google Scholar · View at PubMed
  66. A. D. King, B. B. Ma, Y. Y. Yau et al., “The impact of F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis,” British Journal of Radiology, vol. 81, no. 964, pp. 291–298, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  67. J. Y. Ko, C. P. Wang, L. L. Ting, T. L. Yang, and C. T. Tan, “Endoscopic nasopharyngectomy with potassium-titanyl-phosphate (KTP) laser for early locally recurrent nasopharyngeal carcinoma,” Head and Neck, vol. 31, no. 10, pp. 1309–1315, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  68. C. Piazza, O. Dessouky, G. Peretti, D. Cocco, L. De Benedetto, and P. Nicolai, “Narrow-band imaging: a new tool for evaluation of head and neck squamous cell carcinomas. Review of the literature,” Acta Otorhinolaryngologica Italica, vol. 28, no. 2, pp. 49–54, 2008. View at Google Scholar · View at Scopus
  69. Y.-C. Lin and W.-H. Wang, “Narrow-band imaging for detecting early recurrent nasopharyngeal carcinoma,” Head and Neck, vol. 33, no. 4, pp. 591–594, 2011. View at Publisher · View at Google Scholar · View at PubMed
  70. C. H. Kao, Y. U. C. Shiau, Y. Y. Shen, and R. F. Yen, “Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with technetium-99m methoxyisobutylisonitrile single photon emission computed tomography and computed tomography: comparison with 18-fluoro-2-deoxyglucose positron emission tomography,” Cancer, vol. 94, no. 7, pp. 1981–1986, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  71. R. F. Yen, R. L. Hung, M. H. Pan et al., “18-Fluoro-2-deoxyglucose positron emission tomography in detecting residual/recurrent nasopharyngeal carcinomas and comparison with magnetic resonance imaging,” Cancer, vol. 98, no. 2, pp. 283–287, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  72. R.-F. Yen, R.-L. Hong, K.-Y. Tzen, M.-H. Pan, and T. H. H. Chen, “Whole-body 18F-FDG PET in recurrent or metastatic nasopharyngeal carcinoma,” Journal of Nuclear Medicine, vol. 46, no. 5, pp. 770–774, 2005. View at Google Scholar
  73. S. H. Ng, J. C. Tung-Chieh, S. C. Chan et al., “Clinical usefulness of F-FDG PET in nasopharyngeal carcinoma patients with questionable MRI findings for recurrence,” Journal of Nuclear Medicine, vol. 45, no. 10, pp. 1669–1676, 2004. View at Google Scholar · View at Scopus
  74. T. Liu, W. Xu, W. L. Yan, M. Ye, Y. R. Bai, and G. Huang, “FDG-PET, CT, MRI for diagnosis of local residual or recurrent nasopharyngeal carcinoma, which one is the best? A systematic review,” Radiotherapy and Oncology, vol. 85, no. 3, pp. 327–335, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  75. R. F. Yen, M. F. Yen, R. L. Hong, K. Y. Tzen, C. R. Chien, and T. H. H. Chen, “The cost-utility analysis of 18-fluoro-2-deoxyglucose positron emission tomography in the diagnosis of recurrent nasopharyngeal carcinoma,” Academic Radiology, vol. 16, no. 1, pp. 54–60, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus